News about general reimbursement of medicines
-
Consultation responses on the future reimbursement status of dihydropyridine calcium antagonists (C08CA)
| 19 December 2008 |
The Danish Medicines Agency's assessment of the future reimbursement status of the dihydropyridine calcium antagonists (C08CA) were submitted for consultation with 11 November 2008 as the consultation deadline.